196 related articles for article (PubMed ID: 28848078)
1. Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles.
He X; Yang L; Wang M; Zhuang X; Huang R; Zhu R; Wang S
Cell Physiol Biochem; 2017; 42(6):2281-2294. PubMed ID: 28848078
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression.
He X; Zhu Y; Wang M; Jing G; Zhu R; Wang S
Int J Nanomedicine; 2016; 11():4975-4990. PubMed ID: 27757031
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder.
He XL; Yang L; Wang ZJ; Huang RQ; Zhu RR; Cheng LM
Neural Regen Res; 2021 Mar; 16(3):537-542. PubMed ID: 32985484
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis.
Wang J; Wang H; Zhu R; Liu Q; Fei J; Wang S
Biomaterials; 2015; 53():475-83. PubMed ID: 25890744
[TBL] [Abstract][Full Text] [Related]
5. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
6. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
McLaughlin RJ; Hill MN; Morrish AC; Gorzalka BB
Behav Pharmacol; 2007 Sep; 18(5-6):431-8. PubMed ID: 17762511
[TBL] [Abstract][Full Text] [Related]
7. Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles.
Jiang S; Zhu R; He X; Wang J; Wang M; Qian Y; Wang S
Int J Nanomedicine; 2017; 12():167-178. PubMed ID: 28053531
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Uptake of Curcumin-Loaded Solid Lipid Nanoparticles Exhibit Anti-Inflammatory Activities Superior to Those of Curcumin Through the NF-κB Signaling Pathway.
Wang J; Zhu R; Sun D; Sun X; Geng Z; Liu H; Wang SL
J Biomed Nanotechnol; 2015 Mar; 11(3):403-15. PubMed ID: 26307824
[TBL] [Abstract][Full Text] [Related]
9. Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer.
Wang W; Chen T; Xu H; Ren B; Cheng X; Qi R; Liu H; Wang Y; Yan L; Chen S; Yang Q; Chen C
Molecules; 2018 Jun; 23(7):. PubMed ID: 29966245
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
11. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis.
Shrotriya S; Ranpise N; Satpute P; Vidhate B
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1471-1482. PubMed ID: 28884598
[TBL] [Abstract][Full Text] [Related]
12. Curcumin protects PC12 cells from corticosterone-induced cytotoxicity: possible involvement of the ERK1/2 pathway.
Zhou H; Li X; Gao M
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):236-40. PubMed ID: 19175364
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
14. Anticancer and Antibacterial Properties of Curcumin-Loaded Mannosylated Solid Lipid Nanoparticles for the Treatment of Lung Diseases.
Chae J; Choi Y; Hong J; Kim N; Kim J; Lee HY; Choi J
ACS Appl Bio Mater; 2024 Apr; 7(4):2175-2185. PubMed ID: 38478917
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
Chen Y; Pan L; Jiang M; Li D; Jin L
Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
[TBL] [Abstract][Full Text] [Related]
16. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.
Kakkar V; Muppu SK; Chopra K; Kaur IP
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):339-45. PubMed ID: 23454202
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice.
Steiner MA; Marsicano G; Nestler EJ; Holsboer F; Lutz B; Wotjak CT
Psychoneuroendocrinology; 2008 Jan; 33(1):54-67. PubMed ID: 17976922
[TBL] [Abstract][Full Text] [Related]
18. Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.
Palliyage GH; Hussein N; Mimlitz M; Weeder C; Alnasser MHA; Singh S; Ekpenyong A; Tiwari AK; Chauhan H
Pharm Res; 2021 May; 38(5):851-871. PubMed ID: 33982225
[TBL] [Abstract][Full Text] [Related]
19. Solid Lipid Nanoparticles Enhanced the Neuroprotective Role of Curcumin against Epilepsy through Activation of Bcl-2 Family and P38 MAPK Pathways.
Huang R; Zhu Y; Lin L; Song S; Cheng L; Zhu R
ACS Chem Neurosci; 2020 Jul; 11(13):1985-1995. PubMed ID: 32464055
[TBL] [Abstract][Full Text] [Related]
20. Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats.
Huang Z; Zhong XM; Li ZY; Feng CR; Pan AJ; Mao QQ
Neurosci Lett; 2011 Apr; 493(3):145-8. PubMed ID: 21334417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
